MedTrace Logo

Chronic Kidney Disease and Non-alcoholic Fatty Liver Diseases

NCT04779905 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 62

Last updated 2021-11-02

No results posted yet for this study

Summary

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide. This disease reportedly affects up to 30% of the general population in Western countries, especially in patients with metabolic syndrome, obesity, and type II diabetes. NAFLD is considered to be an independent risk factor for cardiovascular disease and there is accumulating evidence to support a causative role in the development of chronic kidney disease (CKD). So, we aim first to assess the prevalence of chronic kidney disease in NAFLD patients, secondly to detect the association between hepatic fibrosis and CKD in NAFLD patients

Conditions

  • Chronic Kidney Diseases
  • NAFLD

Interventions

DIAGNOSTIC_TEST

urinary albumbin/creatinine ratio

detection of microalbuminuria in nafld patients

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Principal Investigators

  • Radwa Farag, MD · Sohag University

  • Mohamed Amin, MD · Sohag University

  • Shimaa Hemdan, MD · Sohag University

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-28
Primary Completion
2021-07-30
Completion
2021-09-15

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04779905 on ClinicalTrials.gov